Strongbridgebio.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.
- Website Age
n/a
- Alexa Rank no-data
- Country
United States
- IP Address
104.28.8.179
HTML SIZE INFORMATION
Text / Code Ratio
13.80 %
strongbridgebio.com has a website text/code ratio of 13.80 %. Search engine crawlers tend to not pick up pages with inadequate content.
IMPORTANT HTML TAGS AND COUNTS
Titles
H1
No |
Text |
1 |
Rare focus |
2 |
Rare commıtment |
3 |
Rare pa***ıon |
H2
No |
Text |
1 |
Focus on bridging treatment gaps |
2 |
Committed to positive results |
3 |
Pa***ion for compa***ion |
H3
No |
Text |
1 |
Keveyıs® ( dichlorphenamide ) |
2 |
Recorlev® ( levoketoconazole ) |
3 |
Veldoreotide |
H5
No |
Text |
1 |
You are leaving this site |
Text Styling
- STRONG7
- B0
- EM0
- I0
- U0
- CITE0
STRONG
No |
Text |
1 |
FOCUS |
2 |
COMMITMENT |
3 |
Pa***ION |
4 |
Focus |
5 |
Committed |
6 |
Pa***ion |
7 |
© 2020 Strongbridge Biopharma plc |
LINK ANALYSIS
Total Link Count: 62
Internal Link Count
: 41
No |
Text |
Type |
1 |
- |
image |
2 |
Home |
text |
3 |
About Us |
text |
4 |
About Strongbridge |
text |
5 |
Our Team |
text |
6 |
Board of Directors |
text |
7 |
Company History |
text |
8 |
Endocrine Scientific Advisory Board |
text |
9 |
Careers |
text |
10 |
Strongbridge CareConnection |
text |
11 |
Grants and Giving |
text |
12 |
Expanded Access Policy |
text |
13 |
Therapeutic Focus |
text |
14 |
Our Therapeutic Focus |
text |
15 |
Primary Periodic Paralysis |
text |
16 |
Endogenous Cus***ng’s Syndrome |
text |
17 |
Rare Disease Resources |
text |
18 |
Key Publications and Posters |
text |
19 |
Products |
text |
20 |
Rare Disease Portfolio |
text |
21 |
KEVEYIS® (dichlorphenamide) |
text |
22 |
RECORLEV® (levoketoconazole) |
text |
23 |
Veldoreotide |
text |
24 |
Investors |
text |
25 |
Key Publications and Posters |
text |
26 |
Cortendo plc Exchange Offer |
text |
27 |
Board of Directors |
text |
28 |
Management |
text |
29 |
KEVEYIS® ( dichlorphenamide ) Learn more about this FDA-approved product for patients with a rare neuromuscular disease. |
image |
30 |
RECORLEV® ( levoketoconazole ) Cortisol synthesis inhibitor for endogenous Cus***ng’s syndrome is an investigational agent being studied in a second pivotal Phase 3 study. |
image |
31 |
Veldoreotide A novel investigational somatostatin analogue being evaluated for conditions amenable to somatostatin receptor activation. |
image |
32 |
portfolio |
text |
33 |
Learn more about the Strongbridge difference |
text |
34 |
Meet the Strongbridge leaders***p team |
text |
35 |
strongbridgebio.com |
text |
36 |
OK |
text |
37 |
+1 610-254-9200 |
text |
38 |
[email protected] |
text |
39 |
Privacy Statement |
text |
40 |
Compliance Program |
text |
41 |
- |
empty |
External Link Count
: 21
No |
Text |
Type |
1 |
Overview |
text |
2 |
Press Releases |
text |
3 |
Events, Presentations, & Publications |
text |
4 |
Upcoming Events |
text |
5 |
Past Events |
text |
6 |
Presentations |
text |
7 |
Stock Information |
text |
8 |
Stock Quote & Chart |
text |
9 |
Historical Price Lookup |
text |
10 |
Stock Calculator |
text |
11 |
Analyst Coverage |
text |
12 |
2020 Annual General Meeting |
text |
13 |
SEC Filings |
text |
14 |
Cross-Border Transaction – Depositary Receipt |
text |
15 |
Corporate Governance |
text |
16 |
Governance Highlights |
text |
17 |
Committee Charters & Composition |
text |
18 |
Shareholder Services |
text |
19 |
Investor FAQ |
text |
20 |
Email Alerts |
text |
21 |
IR and Media Contacts |
text |
Nofollow Link Count
: 0
Title Link Count
: 0
WEBSITE SERVER INFORMATION
- Service Provider (ISP)
- Cloudflare, Inc.
- Hosted IP Address
- 104.28.8.179
- Hosted Country
- United States
- Host Region
- Virginia , Ashburn
- Latitude and Longitude
- 39.0438 : -77.4874
WEBSITES USING THE SAME C CLASS IP